Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IGFBP3 anticorps (Internal Region)

IGFBP3 Reactivité: Humain, Souris, Rat, Chien WB Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN374871
  • Antigène Voir toutes IGFBP3 Anticorps
    IGFBP3 (Insulin-Like Growth Factor Binding Protein 3 (IGFBP3))
    Épitope
    • 15
    • 11
    • 9
    • 8
    • 7
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reactivité
    • 101
    • 42
    • 33
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain, Souris, Rat, Chien
    Hôte
    • 102
    • 15
    • 1
    • 1
    Chèvre
    Clonalité
    • 103
    • 16
    Polyclonal
    Conjugué
    • 63
    • 15
    • 7
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp IGFBP3 est non-conjugé
    Application
    • 102
    • 48
    • 46
    • 17
    • 13
    • 13
    • 8
    • 7
    • 7
    • 5
    • 5
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Séquence
    C-RYKVDYESQS TDTQN
    Specificité
    This antibody detects IGFBP3. It is expected to recognise both reported isoforms (NP_001013416.1 and NP_000589.2).
    Réactivité croisée (Details)
    Species reactivity (expected):Mouse, Rat, DogSpecies reactivity (tested):Human
    Purification
    Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
    Immunogène
    Peptide from the internal region of the protein sequence according to NP_001013416.1, NP_000589.2.
    Top Product
    Discover our top product IGFBP3 Anticorps primaire
  • Indications d'application
    Peptide ELISA: antibody detection limit dilution 1: 64000. Western blot: 0.02-0.06 μg/mL. Approx 28 kDa band observed in Human Breast cancerlysates (calculated MW of 31.8 kDa according to NP_001013416.1 and 32.8 kDa according toNP_000589.2). An additional band of 58 kDa was consistently observed, however this bandwas not blocked by the immunizing peptide and it is therefore a non-specific signal. Wecall for caution when used for other assays than Western blot.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
  • Antigène
    IGFBP3 (Insulin-Like Growth Factor Binding Protein 3 (IGFBP3))
    Autre désignation
    IGFBP3 (IGFBP3 Produits)
    Synonymes
    anticorps BP-53, anticorps IBP3, anticorps AI649005, anticorps IGFBP-3, anticorps IGgfbp3, anticorps IGF-BP3, anticorps zgc:91788, anticorps IGFBP3, anticorps igfbp3, anticorps insulin like growth factor binding protein 3, anticorps insulin-like growth factor binding protein 3, anticorps IGFBP3, anticorps Igfbp3, anticorps igfbp3, anticorps IGFBP-3, anticorps LOC100305016
    Sujet
    Insulin like growth factor binding protein 3 (IGFBP3) is a member of the superfamily of insulin like growth factor (IGF) binding proteins which include six high affinity IGF binding proteins (IGFBP) and at least four low affinity binding proteins referred to as IGFBP related proteins (IGFBPrP). The IGFBP members are cysteine rich proteins with conserved cysteine residues clustered in the amino terminal and the carboxy terminal regions of the molecule. The cDNA sequence encoding the mature human IGFBP3 is fused to the signal peptide of CD33. Human IGFBP3 is the major IGF binding protein in plasma where it exists in a ternary complex with IGFI or IGFII and an acid labile subunit. IGFBPs hold a central position in IGF ligand-receptor interactions through influences on both the bioavailability and distribution of IGFs in the extracellular environment. Insulin like growth factor binding protein 3 (IGFBP3) can modulate the mitogenic and metabolic effects of the insulin like growth factors (IGFs). Insulin like growth factor binding protein 3 (IGFBP3) is expressed in multiple tissues. The highest expression level is found in the non paranchymal cells of the liver. The expression levels are higher during extrauterine life and peak during puberty. Insulin like growth factors (IGFs) and IGF binding proteins (IGFBPs) play important roles in cell growth and differentiation. IGFBP3 is one of the factors in serum that is responsible for high serum induced apoptosis in PC3 cells, a prostate cancer cell line. IGFBP3 is important in controlling glucose homeostasis with increased urinary levels in type I diabetes with persistent microalbuminuria.Synonyms: IBP-3, IBP3, IGF-BP3, IGF-binding protein 3, IGFBP-3, Insulin-like growth factor-binding protein 3
    ID gène
    3486, 9606
    UniProt
    P17936
    Pathways
    Myometrial Relaxation and Contraction, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagy, Smooth Muscle Cell Migration, Growth Factor Binding
Vous êtes ici:
Support technique